A Multicenter, Double-Blind, 58 Week Rollover Study to Assess the Safety and Tolerability of BMS-820836 in Patients With Treatment Resistant Major Depression
A Multicenter, Double-Blind, 58 Week Rollover Study to Assess the Safety and Tolerability of BMS-820836 in Patients With Treatment Resistant Major Depression
The purpose of this study it to evaluate the long-term safety and tolerability of BMS-820836 in patients with depression.
Inclusion Criteria:
Exclusion Criteria:
Little Rock, Arkansas 72223, United States
Caba, Buenos Aires 1405, Argentina
Caba, Buenos Aires 1425, Argentina
Vishakapattanam, 530002, India